Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production ofInterleukin-4 and Interleukin-10

Francesca Di Gaudio, Matilde Todaro, Diana Di Liberto, Ada Maria Florena, Monica Zerilli, Giorgio Stassi, Lucia Ricci-Vitiani, Ruggero De Maria, Giuseppe Di Gesu', Mariella Patti

Risultato della ricerca: Articlepeer review

119 Citazioni (Scopus)


We investigated the mechanisms responsible for the widespread refractoriness to chemotherapeutic drugs observed in thyroid cancers. We show that malignant epithelial cells from papillary, follicular, and anaplastic thyroid carcinomas express high levels of Bcl-2 and Bcl-xL. Exogenous expression of either Bcl-2 or Bcl-xL in normal thyrocytes was sufficient to prevent chemotherapeutic drug-induced cytotoxicity. All of the histological thyroid cancer variants examined produced interleukin-4 (IL-4) and interleukin-10 (IL-10), which increased Bcl-2 and Bcl-xL levels and protected thyroid cells from chemotherapeutic agents. Exposure to neutralizing antibodies against IL-4 and IL-10 resulted in down-modulation of Bcl-2 and Bcl-xL, death of a considerable percentage of thyroid cancer cells, and sensitization of the residual tumor population to cytotoxic drug-induced apoptosis. In conclusion, autocrine production of IL-4 and IL-10 promotes thyroid tumor cell progression and resistance to chemotherapy through the up-regulation of antiapoptotic proteins. Thus, IL-4 and IL-10 may represent new therapeutic targets for the treatment of thyroid cancer.
Lingua originaleEnglish
pagine (da-a)6784-6790
Numero di pagine7
RivistaCancer Research
Stato di pubblicazionePublished - 2003

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2730???
  • ???subjectarea.asjc.1300.1306???


Entra nei temi di ricerca di 'Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production ofInterleukin-4 and Interleukin-10'. Insieme formano una fingerprint unica.

Cita questo